Skip to main content

Anavex Life Sciences Corp.

AVXL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001314052

No open-market purchases or sales by Anavex Life Sciences Corp. insiders were filed in the last 90 days; 180 institutions reported holding it in 13F filings for Q2 2026, worth $95.8M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Anavex Life Sciences Corp. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of AVXL: Q1 2026 compared with Q2 2026
MeasureQ1 2026Of which not filed for Q2 2026Q2 2026Change
Holders1902180−8
Shares40.0M34.8K37.0M−2.99M (−7.5%)
Value$122.7M$106.8K$95.8M−$26.8M (−21.8%)

2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (25)

Institutions that held Anavex Life Sciences Corp. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to AVXL in Q2 2026
InstitutionSharesValue% of portfolio
Point72 Asset Management, L.P.157,486$407.9K0.00%
Bridgeway Capital Management, LLC123,000$318.6K0.01%
Voleon Capital Management LP63,505$164.5K0.00%
Millennium Management LLC60,483$156.7K0.00%
Abel Hall, LLC56,832$147.2K0.03%
Squarepoint Ops LLC38,423$99.5K0.00%
Schonfeld Strategic Advisors LLC27,577$71.4K0.00%
Jain Global LLC22,002$57.0K0.00%
StoneX Group Inc.18,679$51.4K0.00%
Baird Financial Group, Inc.15,528$40.2K0.00%
Neuberger Berman Group LLC15,188$39.3K0.00%
Thomasville National Bank15,000$38.9K0.00%
Defiance ETFs, LLC13,216$34.1K0.00%
Penserra Capital Management LLC13,216$34.0K0.00%
Massar Capital Management, LP12,729$33.0K0.01%
Visionary Wealth Advisors10,890$28.2K0.00%
Captrust Financial Advisors10,784$27.9K0.00%
Optiver Holding B.V.6,652$17.2K0.00%
EFG International AG700$1.81K0.00%
Security National Bank of Sioux City Iowa475$1.23K0.00%
Capital Advisors, Ltd. LLC484$1.00K0.00%
Natixis360$9320.00%
Quarry LP333$8620.00%
Wealth Enhancement Trust Services, Inc.238$6160.00%
Clearstead Advisors, LLC95$2470.00%

Sold out (33)

Institutions that held Anavex Life Sciences Corp. at the end of Q1 2026 and filed for Q2 2026 without it.

Not filed for Q2 2026 yet (2)

Institutions that held Anavex Life Sciences Corp. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AVXL in Q1 2026 that haven't filed for Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
CWM, LLC34,760$106.7K
Sunbelt Securities, Inc.27$83